Alaunos Therapeutics, Inc. (TCRT)
NASDAQ: TCRT · IEX Real-Time Price · USD
1.810
-0.050 (-2.69%)
At close: Mar 28, 2024, 4:00 PM
1.880
+0.070 (3.87%)
After-hours: Mar 28, 2024, 6:57 PM EDT

Alaunos Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2022202120202019201820172016201520142013 2012 - 2004
Revenue
2.920.4000.156.396.864.331.370.8
Upgrade
Revenue Growth (YoY)
634.17%----97.71%-6.88%58.38%215.51%71.63%0%
Upgrade
Gross Profit
2.920.4000.156.396.864.331.370.8
Upgrade
Selling, General & Admin
13.1427.5627.6719.5319.9214.814.3817.6512.1715.66
Upgrade
Research & Development
25.0249.6452.738.3334.1345.08157.79106.7932.7142.85
Upgrade
Other Operating Expenses
00.7400000000
Upgrade
Operating Expenses
38.1677.9580.3657.8654.0559.88172.17124.4344.8758.51
Upgrade
Operating Income
-35.24-77.55-80.36-57.86-53.91-53.49-165.31-120.1-43.5-57.71
Upgrade
Interest Expense / Income
3.151.1900000000
Upgrade
Other Expense / Income
-0.660.01-0.3959.94-208.150.83-0.01-0.01-11.72-0.61
Upgrade
Pretax Income
-37.73-78.75-79.98-117.8154.24-54.32-165.3-120.09-31.78-57.11
Upgrade
Net Income
-37.73-78.75-79.98-117.8154.24-54.32-165.3-120.09-31.78-57.11
Upgrade
Preferred Dividends
00001718.947.12000
Upgrade
Net Income Common
-37.73-78.75-79.98-117.8137.25-73.26-172.42-120.09-31.78-57.11
Upgrade
Shares Outstanding (Basic)
141414111099876
Upgrade
Shares Outstanding (Diluted)
141414111099876
Upgrade
Shares Change
1.27%2.27%24.82%16.87%4.95%5.02%3.97%24.01%17.67%9.42%
Upgrade
EPS (Basic)
-2.55-5.55-5.70-10.5014.40-7.95-19.80-14.40-4.65-9.90
Upgrade
EPS (Diluted)
-2.55-5.55-5.70-10.5014.40-7.95-19.80-14.40-4.65-9.90
Upgrade
Free Cash Flow
-29.43-64.79-66.79-41.14-49.92-55.41-58.88-0.42-36.84-59.64
Upgrade
Free Cash Flow Per Share
-2.03-4.53-4.78-3.67-5.22-6.07-6.77-0.05-5.46-10.41
Upgrade
Gross Margin
100.00%100.00%--100.00%100.00%100.00%100.00%100.00%100.00%
Upgrade
Operating Margin
-1205.95%-19484.67%---36921.92%-837.27%-2409.37%-2772.39%-3168.17%-7214.13%
Upgrade
Profit Margin
-1291.24%-19786.68%--94004.11%-1146.67%-2513.04%-2772.11%-2314.71%-7138.38%
Upgrade
Free Cash Flow Margin
-1007.02%-16279.15%---34189.04%-867.21%-858.13%-9.74%-2683.39%-7455.00%
Upgrade
EBITDA
-29.4-75.32-78.85-117.17154.82-53.95-165.01-119.73-31.32-56.37
Upgrade
EBITDA Margin
-1006.16%-18923.87%--106040.41%-844.48%-2405.00%-2763.87%-2281.06%-7046.13%
Upgrade
Depreciation & Amortization
5.182.251.130.630.580.370.290.360.460.74
Upgrade
EBIT
-34.58-77.56-79.98-117.8154.24-54.32-165.3-120.09-31.78-57.11
Upgrade
EBIT Margin
-1183.30%-19487.94%--105646.58%-850.26%-2409.23%-2772.11%-2314.71%-7138.38%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).